181 related articles for article (PubMed ID: 22020886)
1. Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma.
Knowles JA; Golden B; Yan L; Carroll WR; Helman EE; Rosenthal EL
Laryngoscope; 2011 Nov; 121(11):2359-65. PubMed ID: 22020886
[TBL] [Abstract][Full Text] [Related]
2. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L
Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925
[TBL] [Abstract][Full Text] [Related]
3. The effect of combination anti-endothelial growth factor receptor and anti-vascular endothelial growth factor receptor 2 targeted therapy on lymph node metastasis: a study in an orthotopic nude mouse model of squamous cell carcinoma of the oral tongue.
Sano D; Choi S; Milas ZL; Zhou G; Galer CE; Su YW; Gule M; Zhao M; Zhu Z; Myers JN
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):411-20. PubMed ID: 19380367
[TBL] [Abstract][Full Text] [Related]
4. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
[TBL] [Abstract][Full Text] [Related]
5. Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck.
Stegeman H; Kaanders JH; Wheeler DL; van der Kogel AJ; Verheijen MM; Waaijer SJ; Iida M; Grénman R; Span PN; Bussink J
BMC Cancer; 2012 Oct; 12():463. PubMed ID: 23046567
[TBL] [Abstract][Full Text] [Related]
6. Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer.
Newman JR; Bohannon IA; Zhang W; Skipper JB; Grizzle WE; Rosenthal EL
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1218-24. PubMed ID: 19015455
[TBL] [Abstract][Full Text] [Related]
7. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.
Pant A; Lee II; Lu Z; Rueda BR; Schink J; Kim JJ
PLoS One; 2012; 7(7):e41593. PubMed ID: 22911820
[TBL] [Abstract][Full Text] [Related]
9. An orthotopic nude mouse model of oral tongue squamous cell carcinoma.
Myers JN; Holsinger FC; Jasser SA; Bekele BN; Fidler IJ
Clin Cancer Res; 2002 Jan; 8(1):293-8. PubMed ID: 11801572
[TBL] [Abstract][Full Text] [Related]
10. The fatty acid synthase inhibitor orlistat reduces the growth and metastasis of orthotopic tongue oral squamous cell carcinomas.
Agostini M; Almeida LY; Bastos DC; Ortega RM; Moreira FS; Seguin F; Zecchin KG; Raposo HF; Oliveira HC; Amoêdo ND; Salo T; Coletta RD; Graner E
Mol Cancer Ther; 2014 Mar; 13(3):585-95. PubMed ID: 24362464
[TBL] [Abstract][Full Text] [Related]
11. Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.
Niu G; Sun X; Cao Q; Courter D; Koong A; Le QT; Gambhir SS; Chen X
Clin Cancer Res; 2010 Apr; 16(7):2095-105. PubMed ID: 20215534
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance.
Rebucci M; Peixoto P; Dewitte A; Wattez N; De Nuncques MA; Rezvoy N; Vautravers-Dewas C; Buisine MP; Guerin E; Peyrat JP; Lartigau E; Lansiaux A
Int J Oncol; 2011 Jan; 38(1):189-200. PubMed ID: 21109940
[TBL] [Abstract][Full Text] [Related]
13. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.
Hirai H; Sootome H; Nakatsuru Y; Miyama K; Taguchi S; Tsujioka K; Ueno Y; Hatch H; Majumder PK; Pan BS; Kotani H
Mol Cancer Ther; 2010 Jul; 9(7):1956-67. PubMed ID: 20571069
[TBL] [Abstract][Full Text] [Related]
14. A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma.
Sweeny L; Hartman YE; Zinn KR; Prudent JR; Marshall DJ; Shekhani MS; Rosenthal EL
Oral Oncol; 2013 Oct; 49(10):991-7. PubMed ID: 23920309
[TBL] [Abstract][Full Text] [Related]
15. Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximab.
Iida M; Brand TM; Campbell DA; Starr MM; Luthar N; Traynor AM; Wheeler DL
Cancer Biol Ther; 2013 Jun; 14(6):481-91. PubMed ID: 23760490
[TBL] [Abstract][Full Text] [Related]
16. Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer.
Agarwal E; Chaudhuri A; Leiphrakpam PD; Haferbier KL; Brattain MG; Chowdhury S
BMC Cancer; 2014 Mar; 14():145. PubMed ID: 24581231
[TBL] [Abstract][Full Text] [Related]
17. Optical imaging predicts tumor response to anti-EGFR therapy.
Helman EE; Newman JR; Dean NR; Zhang W; Zinn KR; Rosenthal EL
Cancer Biol Ther; 2010 Jul; 10(2):166-71. PubMed ID: 20505368
[TBL] [Abstract][Full Text] [Related]
18. AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake.
Rashmi R; DeSelm C; Helms C; Bowcock A; Rogers BE; Rader JL; Rader J; Grigsby PW; Schwarz JK
PLoS One; 2014; 9(4):e92948. PubMed ID: 24705275
[TBL] [Abstract][Full Text] [Related]
19. Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models.
Ekshyyan O; Moore-Medlin TN; Raley MC; Sonavane K; Rong X; Brodt MA; Abreo F; Alexander JS; Nathan CA
BMC Cancer; 2013 Jul; 13():320. PubMed ID: 23815869
[TBL] [Abstract][Full Text] [Related]
20. Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in vitro and in vivo.
Heath CH; Sorace A; Knowles J; Rosenthal E; Hoyt K
Otolaryngol Head Neck Surg; 2012 Jun; 146(6):938-45. PubMed ID: 22323435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
